BILLS-113hr4592ih.pdf

15 2010 May 10, 2014 Jkt 039200 4592 IH 2014 04:10 May 13 6 years 2015 through 2019 fiscal years 2015 through 2019 later than 60 days fiscal year 2014 years 2015 through 2019 30 days 3-year 21:19 May 13 today annual MAY 7, 2014

SESSION H. R. 4592 the ‘‘Hereditary

Treatment Center of Excellence

the United States of America 4592 IH

American

HHT SEC the Public Health Service AVM tional Institutes of Health the National Institutes of Health U.S.C. the Centers for Disease Control TELANGIECTASIA HHT Treatment Centers Blood Institute the Paul Coverdell National CONGRESS National the Chair of the Committee the Committee on Ways and Means Excellence THE HOUSE OF REPRESENTATIVES the National Institutes of Diabetes Coordinating Committee Medicare HHT COORDINATING COMMITTEE Health MEDPAR the National Cancer Institute Institute of Neurological Disorders the Public Health Service Act the Centers for Medicare & Medicaid Services House of Representa- the National Center on Birth Defects the Office of Rare Diseases tem NATIONAL INSTITUTES OF HEALTH the Centers for Disease Control and Prevention RESPONSIBILITIES.—The Committee Disease Control and Prevention HHT Treatment Centers of Excellence Control and Prevention velop the Website of the Department of 20 Health and Human Services the HHT Coordinating the Department of Health and Human Services Centers Telangiectasia Diagnosis and Treatment Act Shriver National Institute of Child Health the National Cancer Senate APPROPRIATIONS

VerDate Mar GERLACH HIMES Eunice Kennedy Lung

stroke diagnosis screening suffer genetic brain disease control early control prevention centers disease detection intervention lung disease collaborative